Overview

Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA)

Status:
Completed

Trial end date:
2009-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this study was to evaluate the safety and efficacy of multiple courses of AZLI in patients with cystic fibrosis (CF) and lung infection due to Pseudomonas aeruginosa (PA).

Phase:

Phase 3

Details

Lead Sponsor:

Gilead Sciences

Treatments:

Aztreonam